Literature DB >> 28723482

Surveillance of Small Renal Masses in Young Patients: A Viable Option in the Appropriate Candidate.

Alexander Kutikov1.   

Abstract

In young patients the risks of intervention for a renal mass are generally low, the perceived oncologic stakes are significant, and the burden for life-long close monitoring is often judged to be unreasonable. Nevertheless, in an appropriately selected patient for whom a period of active surveillance presents significant value, an interval of close clinical monitoring is a safe and reasonable approach.
Copyright © 2017 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Year:  2017        PMID: 28723482     DOI: 10.1016/j.euf.2016.12.007

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  3 in total

Review 1.  Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.

Authors:  Serge Ginzburg; Jeffrey J Tomaszewski; Alexander Kutikov
Journal:  Nat Rev Urol       Date:  2017-09-12       Impact factor: 14.432

2.  Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.

Authors:  Mark W Ball; Julie Y An; Patrick T Gomella; Rabindra Gautam; Christopher J Ricketts; Cathy D Vocke; Laura S Schmidt; Maria J Merino; Ramaprasad Srinivasan; Ashkan A Malayeri; Adam R Metwalli; W Marston Linehan
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

Review 3.  Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic.

Authors:  Christopher J D Wallis; Giacomo Novara; Laura Marandino; Axel Bex; Ashish M Kamat; R Jeffrey Karnes; Todd M Morgan; Nicolas Mottet; Silke Gillessen; Alberto Bossi; Morgan Roupret; Thomas Powles; Andrea Necchi; James W F Catto; Zachary Klaassen
Journal:  Eur Urol       Date:  2020-05-03       Impact factor: 20.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.